These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35022810)

  • 1. Initial comparative analysis of pulmonary involvement on HRCT between vaccinated and non-vaccinated subjects of COVID-19.
    Verma A; Kumar I; Singh PK; Ansari MS; Singh HA; Sonkar S; Prakash A; Ojha R; Shukla RC
    Eur Radiol; 2022 Jun; 32(6):4275-4283. PubMed ID: 35022810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Severity Score (TSS) comparison in vaccinated and unvaccinated patients during the fourth wave (December 2021 - January 2022) of COVID-19 in Italy.
    Russo GM; Mangoni di Santo Stefano ML; Belfiore MP; Annunziata G; Zoi E; Gallo L; Ciani G; Urraro F; Nardone V; Reginelli A; Cappabianca S
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5971-5977. PubMed ID: 36066174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chest CT features of COVID-19 in vaccinated versus unvaccinated patients: use of CT severity score and outcome analysis.
    Masci GM; Izzo A; Bonito G; Marchitelli L; Guiducci E; Ciaglia S; Lucchese S; Corso L; Valenti A; Malzone L; Pasculli P; Ciardi MR; La Torre G; Galardo G; Alessandri F; Vullo F; Manganaro L; Iafrate F; Catalano C; Ricci P
    Radiol Med; 2023 Aug; 128(8):934-943. PubMed ID: 37354309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumonia Frequency and Severity in Patients With Symptomatic COVID-19: Impact of mRNA and Adenovirus Vector Vaccines.
    Vicini S; Bellini D; Iannarelli A; Rengo M; Pelle G; Ruggiero S; Fusco M; Ambrogi C; Carbone I
    AJR Am J Roentgenol; 2022 Nov; 219(5):752-761. PubMed ID: 35642761
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients.
    Lai M; Wang K; Ding C; Yin Y; Lin X; Xu C; Hu Z; Peng Z
    Ann Clin Microbiol Antimicrob; 2023 Mar; 22(1):22. PubMed ID: 36944961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chest computed tomography of suspected COVID-19 pneumonia in the Emergency Department: comparative analysis between patients with different vaccination status.
    Carbonaro LA; Braga F; Gemma P; Carlicchi E; Pata A; Conca M; Rizzetto F; Vanzulli A
    Pol J Radiol; 2023; 88():e80-e88. PubMed ID: 36910888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of CT signs, radiomic features and clinical characteristics for delta variant COVID-19 patients with different vaccination status.
    Wei H; Shao Z; Tai J; Fu F; Lv C; Guo Z; Wu Y; Chen L; Bai Y; Wu Q; Yu X; Mu X; Shao F; Wang M
    BMC Med Imaging; 2022 Nov; 22(1):209. PubMed ID: 36447133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental health and chest CT scores mediate the relationship between COVID-19 vaccination status and seroconversion time: A cross-sectional observational study in B.1.617.2 (Delta) infection patients.
    Zhang W; Chen Q; Dai J; Lu J; Li J; Yi Y; Fu L; Li X; Liu J; Liufu J; Long C; Zhang B
    Front Public Health; 2022; 10():974848. PubMed ID: 36339206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Vaccination on COVID-19 Severity and Outcome: A Comparative Study in a Tertiary Care Hospital.
    Yadav YR; Maheshwari S; Garg A; Ram A; Singh S; Mangal S; Maheshwari K; Notani V; Sharma S; Bansal V
    J Assoc Physicians India; 2023 Dec; 71(12):14-16. PubMed ID: 38736048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Sacco C; Del Manso M; Mateo-Urdiales A; Rota MC; Petrone D; Riccardo F; Bella A; Siddu A; Battilomo S; Proietti V; Popoli P; Menniti Ippolito F; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Fabiani M;
    Lancet; 2022 Jul; 400(10346):97-103. PubMed ID: 35780801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.
    Smith JB; Gonzales EG; Li BH; Langer-Gould A
    JAMA Netw Open; 2022 Dec; 5(12):e2248664. PubMed ID: 36576740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.
    Dick A; Rosenbloom JI; Karavani G; Gutman-Ido E; Lessans N; Chill HH
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100637. PubMed ID: 35398583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of SARS-CoV-2 vaccination on the epidemiological and clinical characteristics of imported COVID-19 cases in Chengdu].
    Yue Y; Liang X; Mao Y; Hu M; Han DL; Su LY; Chen H; Fan SF; Zhang XC; Yang F; Yuan QW; Liu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Aug; 42(8):1365-1370. PubMed ID: 34814555
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Vaccination on Markers of Severity among Elderly Covid-19 Patients-A Retrospective Comparative Analysis.
    Saha L; Thakuria R; Swami A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.
    Corchado-Garcia J; Zemmour D; Hughes T; Bandi H; Cristea-Platon T; Lenehan P; Pawlowski C; Bade S; O'Horo JC; Gores GJ; Williams AW; Badley AD; Halamka J; Virk A; Swift MD; Wagner T; Soundararajan V
    JAMA Netw Open; 2021 Nov; 4(11):e2132540. PubMed ID: 34726743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
    Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
    BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.